James Clubb
MSc, Head of Biomarker Research
James Clubb has expertise in developing cell and gene therapies for regenerative medicine and treating solid tumour cancers. Prior to joining TILT Biotherapeutics full-time, James was a Marie Skłodowska-Curie PhD fellow at TILT Biotherapeutics and the Cancer Gene Therapy Group at the University of Helsinki. James now leads the correlative analysis strategy for TILT’s ongoing clinical trials.
